Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

Delray Medical Center First Hospital in South Florida to Use New Therapy

Aug 3, 2017

Delray Medical Center is the first hospital in South Florida to implant a new device used to seal off the left atrial appendage (LAA) — a small appendage connected to the left atrium — in patients diagnosed with non-valvular atrial fibrillation (AF). The device, the Abbott AMPLATZER™ Amulet™ Left Atrial Appendage Occluder, is currently being evaluated in the AMPLATZER Amulet U.S. IDE Clinical Trial to determine the device’s safety and effectiveness.

Dr. Brij Maini, Regional Medical Director of Transcatheter Therapies for Tenet Healthcare’s Coastal Division, implanted the AMPLATZER Amulet occluder, which was designed to reduce the risk of stroke in patients suffering from non-valvular AF.
 
“We’re extremely pleased with the results of this technology, and what it can do to enhance patient care, said Dr. Maini. “This procedure can help extend lives and improve outcomes for those who are suffering from atrial fibrillation.”
 
The AMPLATZER Amulet occluder works by blocking the LAA at its opening, which minimizes the opportunity for blood clots to form in the LAA and migrate into the bloodstream. The occluder is built with a longer lobe and waist than the previous version and was designed to allow for easier and more stable placement, which could result in shorter procedure times for patients. The device is offered in eight sizes to accommodate varying anatomies and is designed to address a wider range of complex patient anatomies.

Original Article via SouthFloridaHospitalNews.com

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.

Find a Doctor

Need a doctor for your care?